LINC00515
LINC00515 is a long intergenic noncoding RNA [1].
Contents
Annotated Information
Name
Approved symbol:LINC00515
Approved name:long intergenic non-protein coding RNA 515
HGNC ID:HGNC:16019
Previous name:chromosome 21 open reading frame 71
Alias symbol:PRED21
RefSeq ID:NR_024092
pubmed_id:31140829
prev_symbol :C21orf71
Characteristics
Please input information here.
Function
LINC00515 downregulation was correlated with platinum resistance and relapse-free survival (RFS) of HGSOC (p < 0.05)[1].
Regulation
Please input information here.
Expression
Please input information here.
Diseases
high-grade serous ovarian cancer (HGSOC)[1]
Labs working on this lncRNA
- Zhejiang Cancer Research Institute, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, PR China.[1]
- Key Laboratory Diagnosis & Treatment Technology on Thoracic Oncology of Zhejiang Province, Hangzhou, Zhejiang, PR China.[1]
- Center for Medicinal Resources Research, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, PR China.[1]
- Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, PR China.[1]
- Laboratory Medicine, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, PR China.[1]
- Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, PR China.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Ni MW, Zhou J, Zhang YL, Zhou GM, Zhang SJ, Feng JG, Xu Q, Zhou Y, Mou HZ, Zheng ZG. Downregulation of LINC00515 in high-grade serous ovarian cancer and its relationship with platinum resistance. Biomark Med. 2019 May;13(7):535-543. doi: 10.2217/bmm-2018-0382. Epub 2019 May 29. PMID: 31140829.
